Loading...
  • patients
  • High incidence of skin diseases (such as psoriasis, eczema, and skin cancer), increasing inclination of patients towards pain-free drug delivery, launch of new topical products, and increasing focus of prominent players on strengthening their presence in the North American market (through acquisitions and expansions) are expected to drive the growth of this regional market. (marketsandmarkets.com)
  • delivery
  • The topical drug delivery market is expected to reach USD 125.88 Billion by 2021 from USD 92.40 Billion in 2016 at a CAGR of 6.4% during the forecast period. (marketsandmarkets.com)
  • The topical drug delivery market is a fragmented market with several global as well as local players operating in various market segments. (marketsandmarkets.com)
  • Clinical
  • Despite not meeting the primary endpoint, the results of this phase III trial suggest that topical administration of the TLR-9 agonist DIMS0150 is able to induce remission in ulcerative colitis patients, as judged by objective clinical and endoscopic measures. (ecco-ibd.eu)
  • adverse
  • Short-term administration of NGF eye-drops caused neither significant adverse effects nor visual function losses in the tested RP patients. (biomedcentral.com)
  • However, antibodies need to be delivered by (repeat) intravitreal injection, a laborious administration procedure associated with the potential for serious adverse events. (arvojournals.org)
  • physiological
  • The book attempts to take the reader logically from the physiological and pathological aspects through to the reasoning behind topical medication. (elsevier.com)
  • daily
  • The study was a single-center, open-label phase II trial, enrolling 10 participants with bilateral GA. Topical 0.45% OT-551 was administered in one randomly assigned eye three times daily for 2 years. (arvojournals.org)